Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Leo J. Schep, Robin J. Slaughter, Martin Watts, Elliot Mackenzie & Paul Gee. (2023) The clinical toxicology of ketamine. Clinical Toxicology 61:6, pages 415-428.
Read now
Read now
Luke A. Jelen & James M. Stone. (2021) Ketamine for depression. International Review of Psychiatry 33:3, pages 207-228.
Read now
Read now
Nicholas Denomme$suffix/text()$suffix/text(). (2018) The Domino Effect: Ed Domino’s early studies of Psychoactive Drugs. Journal of Psychoactive Drugs 50:4, pages 298-305.
Read now
Read now
Articles from other publishers (40)
Jeongseop Kim, Tae-Eun Kim, Seung-Hwan Lee & Ja Wook Koo. (2023) The Role of Glutamate Underlying Treatment-resistant Depression. Clinical Psychopharmacology and Neuroscience 21:3, pages 429-446.
Crossref
Crossref
Miriam Marguilho, Inês Figueiredo & Pedro Castro-Rodrigues. (2022) A unified model of ketamine’s dissociative and psychedelic properties. Journal of Psychopharmacology 37:1, pages 14-32.
Crossref
Crossref
Fúlvio Rieli Mendes, Cristiane dos Santos Costa, Victor Distefano Wiltenburg, Gabriela Morales-Lima, João Ariel Bonar Fernandes & Renato Filev. (2022) Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research. Addiction Neuroscience 3, pages 100025.
Crossref
Crossref
Yoosuk An, Seon Young Park & Ung Gu Kang. (2022) “Drugs of Abuse” as a “New Antidepressant”: - A Review on Pharmacological Mechanisms, Antidepressant Effects, and Abuse Potential. Journal of Korean Neuropsychiatric Association 61:4, pages 243.
Crossref
Crossref
Madison N. Irwin & Amy VandenBerg. (2021) Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action. Mental Health Clinician 11:3, pages 200-210.
Crossref
Crossref
Benjamin Sanders & Abdul Q. Brula. (2021) Intranasal esketamine: From origins to future implications in treatment-resistant depression. Journal of Psychiatric Research 137, pages 29-35.
Crossref
Crossref
Jon Y. Zhou, Perry Hamilton, Stephen Macres, Matthew Peña & Schirin Tang. (2020) Update on Ketamine. Advances in Anesthesia 38, pages 97-113.
Crossref
Crossref
Jacek Wróbel, Władysław Średniawa, Gabriela Jurkiewicz, Jarosław Żygierewicz, Daniel K. Wójcik, Miles Adrian Whittington & Mark Jeremy Hunt. (2020) Nasal respiration is necessary for ketamine-dependent high frequency network oscillations and behavioral hyperactivity in rats. Scientific Reports 10:1.
Crossref
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Crossref
Amanda J. Jenkins & Madeleine J. Gates. 2020. Principles of Forensic Toxicology. Principles of Forensic Toxicology
467
489
.
Chiao-Ching Li, Sheng-Tang Wu, Tai-Lung Cha, Guang-Huan Sun, Dah-Shyong Yu & En Meng. (2019) A survey for ketamine abuse and its relation to the lower urinary tract symptoms in Taiwan. Scientific Reports 9:1.
Crossref
Crossref
M. V. Zozulya, A. I. Lenkin, I. S. Kurapeev & K. M. Lebedinskii. (2019) Postoperative cognitive disorders: the pathogenesis, methods of prevention and treatment. Anesteziologiya i Reanimatologiya:3, pages 25.
Crossref
Crossref
Jeanette L. Bertron, Mabel Seto & Craig W. Lindsley. (2018) DARK Classics in Chemical Neuroscience: Phencyclidine (PCP). ACS Chemical Neuroscience 9:10, pages 2459-2474.
Crossref
Crossref
Linda Li & Phillip E. Vlisides. (2016) Ketamine: 50 Years of Modulating the Mind. Frontiers in Human Neuroscience 10.
Crossref
Crossref
Hamilton Morris & Jason Wallach. (2014) From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis 6:7-8, pages 614-632.
Crossref
Crossref
Wouter Koek. (1999) N-Methyl-d-Aspartate Antagonists and Drug Discrimination. Pharmacology Biochemistry and Behavior 64:2, pages 275-281.
Crossref
Crossref
Frank Sams-Dodd. (1999) Phencyclidine in the Social Interaction Test: An Animal Model of Schizophrenia with Face and Predictive Validity. Reviews in the Neurosciences 10:1.
Crossref
Crossref
J.F.W. Deakin, M.D.C. Simpson, P. Slater & J.S.E. Hellewell. (2016) Familial and developmental abnormalities of frontal lobe function and neurochemistry in schizophrenia. Journal of Psychopharmacology 11:2, pages 133-142.
Crossref
Crossref
J.F.W. Deakin & M.D.C. Simpson. (1997) A two-process theory of schizophrenia: Evidence from studies in post-mortem brain. Journal of Psychiatric Research 31:2, pages 277-295.
Crossref
Crossref
Shakir Sarhan, Janice M Hitchcock, Christine A Grauffel & Joseph G Wettstein. (1997) Comparative Antipsychotic Profiles of Neurotensin and a Related Systemically Active Peptide Agonist. Peptides 18:8, pages 1223-1227.
Crossref
Crossref
Diana H. Fishbein. (1996) Female PCP-using jail detainees: Proneness to violence and gender differences. Addictive Behaviors 21:2, pages 155-172.
Crossref
Crossref
David M. Jackson, Christina Johansson, Li-Marie Lindgren & Annelie Bengtsson. (1994) Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats. Pharmacology Biochemistry and Behavior 48:2, pages 465-471.
Crossref
Crossref
D. M. Jackson, C. Ryan, J. Evenden & N. Mohell. (1994) Preclinical findings with new antipsychotic agents: what makes them atypical?. Acta Psychiatrica Scandinavica 89:s380, pages 41-48.
Crossref
Crossref
Xue-Min Gao, Osamu Shirakawa, Fu Du & Carol A. Tamminga. (1993) Delayed regional metabolic actions of phencyclidine. European Journal of Pharmacology 241:1, pages 7-15.
Crossref
Crossref
James F. Buchanan, Howard E. McKinneyJr.Jr., Gregory N. Hayner & Darryl S. Inaba. 1992. Applied Therapeutics. Applied Therapeutics
1145
1173
.
Q. Yang, T. Moroji, Y. Takamatsu, Y. Hagino & M. Okuwa. (1991) The effects of intraperitoneally administered phencyclidine on the central nervous system: Behavioral and neurochemical studies. Neuropeptides 19:2, pages 77-90.
Crossref
Crossref
Diana H. Fishbein. (2006) Medicalizing the drug war. Behavioral Sciences & the Law 9:3, pages 323-344.
Crossref
Crossref
DIANA H. FISHBEIN. (2006) BIOLOGICAL PERSPECTIVES IN CRIMINOLOGY *. Criminology 28:1, pages 27-72.
Crossref
Crossref
Lynn McCardle & Diana H. Fishbein. (1989) The self-reported effects of PCP on human aggression. Addictive Behaviors 14:4, pages 465-472.
Crossref
Crossref
Masayuki Hiramatsu, Toshitaka Nabeshima, Hiroshi Furukawa & Tsutomu Kameyama. (1987) Different effects of ethylketocyclazocine on phencyclidine- and N-allylnormetazocine-induced stereotyped behaviors in rats. Pharmacology Biochemistry and Behavior 28:4, pages 489-494.
Crossref
Crossref
Toshitaka Nabeshima, Masayuki Hiramatsu & Tsutomu Kameyama. (1986) Phencyclidine-induced stereotyped behaviors after injection of ethylketocyclazocine, Mr 2266 and naltrexone in rats. Brain Research 378:2, pages 234-239.
Crossref
Crossref
Omanand Koul, James E. March, Raqhupathy Sarma, Cynthia Griffiths & Dale G. Deutsch. (2006) Effect of Phencyclidine on the Metabolism of Individual Brain Proteins. Journal of Neurochemistry 46:2, pages 470-474.
Crossref
Crossref
Wolfram KeupK.-A. Kovar. 1985. Biologie der Sucht. Biologie der Sucht
307
314
.
Mohamed A. Bayorh, Zofia Zukowska-Grojec, Miklos Palkovits & Irwin J. Kopin. (1984) Effect of phencyclidine (PCP) on blood pressure and catecholamine levels in discrete brain nuclei. Brain Research 321:2, pages 315-318.
Crossref
Crossref
Dale G. Deutsch, Omanand Koul & Roger S. Kersten. (2006) Phencyclidine and Analogues: Effects on Brain Protein Synthesis. Journal of Neurochemistry 42:2, pages 407-411.
Crossref
Crossref
Toshitaka Nabeshima, Kazumasa Yamaguchi, Kiyofumi Yamada, Masayuki Hiramatsu, Hiroshi Furukawa & Tsutomu Kameyama. (1983) Phencyclidine-induced stereotyped behaviors in rats following specific neurotoxin lesions of the striatum. European Journal of Pharmacology 93:3-4, pages 229-234.
Crossref
Crossref
Toshitaka Nabeshima, Kiyofumi Yamada, Kazumasa Yamaguchi, Masayuki Hiramatsu, Hiroshi Furukawa & Tsutomu Kameyama. (1983) Effect of lesions in the striatum. nucleus accumbens and medial raphe on phencyclidine-induced stereotyped behaviors and hyperactivity in rats. European Journal of Pharmacology 91:4, pages 455-462.
Crossref
Crossref
T.E. Ary & H.L. Komiskey. (1982) Phencyclidine-induced release of [3H]dopamine from chopped striatal tissue. Neuropharmacology 21:7, pages 639-645.
Crossref
Crossref
Graeme Henderson. (1982) Phenycyclidine A widely abused but little understood psychotomimetic agent. Trends in Pharmacological Sciences 3, pages 248-250.
Crossref
Crossref
John F. Bowyer. (1982) Phencyclidine inhibition of the rate of development of amygdaloid kindled seizures. Experimental Neurology 75:1, pages 173-183.
Crossref
Crossref